myosin light chain
myosin light chain kinase
myosin light chain phosphatase
myosin phosphatase targeting subunit
protein phosphatase 1
spontaneous transient outward current
This study examined whether elevated intravascular pressure stimulates asynchronous Ca2+ waves in cerebral arterial smooth muscle cells and if their generation contributes to myogenic tone development. The endothelium was removed from rat cerebral arteries, which were then mounted in an arteriograph, pressurized (20–100 mmHg) and examined under a variety of experimental conditions. Diameter and membrane potential (VM) were monitored using conventional techniques; Ca2+ wave generation and myosin light chain (MLC20)/MYPT1 (myosin phosphatase targeting subunit) phosphorylation were assessed by confocal microscopy and Western blot analysis, respectively. Elevating intravascular pressure increased the proportion of smooth muscle cells firing asynchronous Ca2+ waves as well as event frequency. Ca2+ wave augmentation occurred primarily at lower intravascular pressures (<60 mmHg) and ryanodine, a plant alkaloid that depletes the sarcoplasmic reticulum (SR) of Ca2+, eliminated these events. Ca2+ wave generation was voltage insensitive as Ca2+ channel blockade and perturbations in extracellular [K+] had little effect on measured parameters. Ryanodine-induced inhibition of Ca2+ waves attenuated myogenic tone and MLC20 phosphorylation without altering arterial VM. Thapsigargin, an SR Ca2+-ATPase inhibitor also attenuated Ca2+ waves, pressure-induced constriction and MLC20 phosphorylation. The SR-driven component of the myogenic response was proportionally greater at lower intravascular pressures and subsequent MYPT1 phosphorylation measures revealed that SR Ca2+ waves facilitated pressure-induced MLC20 phosphorylation through mechanisms that include myosin light chain phosphatase inhibition. Cumulatively, our findings show that mechanical stimuli augment Ca2+ wave generation in arterial smooth muscle and that these transient events facilitate tone development particularly at lower intravascular pressures by providing a proportion of the Ca2+ required to directly control MLC20 phosphorylation.
Cerebral arteries form an integrated vascular network that controls the magnitude and distribution of tissue blood flow (Segal & Duling, 1986; Segal, 2000). Under dynamic conditions, tone within this network is regulated by multiple stimuli including blood flow (Garcia-Roldan & Bevan, 1990; Koller & Kaley, 1991), neuronal activity (Brayden & Bevan, 1985; Si & Lee, 2002), tissue metabolism (Filosa et al. 2006; Harder et al. 1998) and intraluminal pressure (Bayliss, 1902; Knot & Nelson, 1998). It was a century ago when Bayliss first surmised that resistance arteries could respond to a fluctuating change in blood pressure (Bayliss, 1902). The so-called ‘myogenic response’ has been observed in a variety of vascular beds and is particularly prominent in the cerebral vasculature where constant perfusion must be maintained over a range of blood pressures (Welsh et al. 2000, 2002; Hill et al. 2001; Loutzenhiser et al. 2002; Slish et al. 2002). Like all stimuli, intravascular pressure regulates arterial tone by altering myosin light chain (MLC20) phosphorylation via the dynamic regulation of myosin light chain kinase (MLCK) and phosphatase (MLCP) (Knot & Nelson, 1995; Davis et al. 2001; Johnson et al. 2009). While the precise signalling mechanism has not been fully resolved, a rise in cytosolic [Ca2+] is generally thought to be a key mediating step (Knot & Nelson, 1995, 1998; Knot et al. 1998). Given the maintained nature of the myogenic response, it is generally presumed that the Ca2+ elevation is sustained and induced by the depolarization of arterial smooth muscle and the activation of voltage-operated Ca2+ channels (Knot & Nelson, 1995, 1998; Knot et al. 1998; Welsh et al. 2000, 2002).
The sarcoplasmic reticulum (SR) is an internal store which discretely releases Ca2+ when ryanodine- (RyR) or inositol triphosphate- (IP3R) sensitive receptors are activated (Boittin et al. 1999; Jaggar & Nelson, 2000; Perez et al. 2001; Lee et al. 2005). In vascular tissue, SR Ca2+ release takes several forms including that of a ‘Ca2+ spark’ and a ‘Ca2+ wave’. Ca2+ sparks are discrete voltage-dependent events that activate large-conductance Ca2+-activated K+ channels (BK) and elicit spontaneous transient outward currents (STOCs) (Jaggar et al. 1998a, 2000; Perez et al. 2001). In intact arteries, STOCs are electrically transformed through the passive cable properties of vascular cells into a sustained hyperpolarization that feeds back negatively upon constrictor responses (Jaggar et al. 1998b; Knot et al. 1998; Diep et al. 2005). Ca2+ waves are slower temporal events that generally propagate from end to end and which are asynchronous among neighbouring smooth muscle cells (Boittin et al. 1999; Jaggar & Nelson, 2000; Lee et al. 2005). Unlike sparks, Ca2+ waves are thought to facilitate arterial constriction through one of two potential mechanisms. The first centres on the idea that these events deliver a proportion of the Ca2+ that controls the signalling pathways associated with MLCK or MLCP (Kuo et al. 2003; Lee et al. 2005). The second highlights an indirect effect whereby Ca2+ waves activate an inward current to depolarize smooth muscle and subsequently elevate Ca2+ influx through voltage-operated Ca2+ channels (Gonzales et al. 2010). While agonists are known to generate Ca2+ waves, it is less certain whether mechanical stimuli, (i.e. intravascular pressure) initiate a similar response. Indeed, existing studies have presented conflicting findings ranging from no Ca2+ wave generation, to robust production, to a subtler Ca2+ ripple phenomenon (Miriel et al. 1999; Jaggar, 2001; Zacharia et al. 2007).
The purpose of this study was to examine whether elevated intravascular pressure stimulates Ca2+ waves and how their generation might contribute to myogenic tone development in the cerebral circulation. To accomplish this objective, rat cerebral arteries were mounted and pressurized while arterial diameter, Ca2+ waves and membrane potential (VM) were monitored, and myosin light chain (MLC20)/MYPT1 phosphorylation determined. Our findings reveal that elevated intravascular pressure stimulates SR release and induces the generation of Ca2+ waves in a voltage-insensitive manner. This rise in Ca2+ wave generation was particularly evident at intravascular pressures less than 60 mmHg. A range of functional experiments revealed that these asynchronous events facilitate myogenic tone development by enhancing MLC20 phosphorylation. Further measurements of MYPT1 phosphorylation illustrated that SR Ca2+ waves augment MLC20 phosphorylation through mechanisms that include MLCP inhibition. Overall, this investigation provides definitive evidence that the asynchronous and transient nature of pressure-induced Ca2+ waves does not preclude these SR-driven events from directly participating in MLC20 phosphorylation and the long-term maintenance of arterial tone.
Animal procedures were approved by the Animal Care and Use Committee at the University of Calgary. Briefly, female Sprague–Dawley rats (10–12 weeks of age) were killed via carbon dioxide asphyxiation. The brain was carefully removed and placed in cold phosphate-buffered (pH 7.4) saline solution containing (in mm): 138 NaCl, 3 KCl, 10 Na2HPO4, 2 NaH2PO4, 5 glucose, 0.1 CaCl2 and 0.1 MgSO4. Middle and posterior cerebral arteries were carefully dissected out of surrounding tissue and cut into 2–3 mm segments.
Arterial segments were mounted in a customized arteriograph and superfused with warm (37°C) physiological salt solution (PSS; pH 7.4; 21% O2, 5% CO2, balance N2) containing (in mm): 119 NaCl, 4.7 KCl, 20 NaHCO3, 1.1 KH2PO4, 1.2 MgSO4, 1.6 CaCl2 and 10 glucose (Welsh et al. 2000). To limit the endothelium's tonic dilatory influence on myogenic tone development (Kuo et al. 1991; Knot et al. 1999), these cells were removed by passing air bubbles through the vessel lumen (1–2 min); successful removal was confirmed by the loss of bradykinin-induced dilatation. Arteries were equilibrated for 30 min at 15 mmHg and contractile responsiveness assessed by briefly exposing (∼10 s) tissue to 60 mm KCl. Following equilibration, intravascular pressure was increased incrementally from 15 to 100 mmHg and pressure-induced diameter monitored with an automated edge detection system (IonOptix, MA, USA). After collecting these control measures, arteries were returned to 15 mmHg and equilibrated for 5 min with PSS containing: (1) diltiazem (30 μm) ± ryanodine (10 or 50 m) or thapsigargin (200 nm); (2) diltiazem + zero externally added Ca2+; (3) nifedipine (0.1–1 μm) ± ryanodine; or (4) zero externally added Ca2++ 2 mm EGTA (referred to as Ca2+-free PSS). Vasomotor responsiveness to elevated intravascular pressure was then reassessed.
Supplementary experiments were also performed in which cerebral arteries were first pressurized to 80 mmHg and then exposed to 10 μm ryanodine. Following a 5 min period in which vessels actively constricted, arteries were briefly hyperpolarized (5 min) by reducing intravascular pressure (15 mmHg) and superfusing tissues with a ryanodine–PSS in which extracellular [K+] was elevated to 15 mm to augment the activity of inward rectifying K+ channels (Smith et al. 2008). Arteries were then re-pressurized and returned to a standard ryanodine–PSS. In a subgroup of these experiments, investigators modified the elevated K+–ryanodine–PSS by replacing NaCl with LiCl (120 or 60 mm) or NMDG-Cl (60 mm) to diminish Na+/Ca2+ exchanger activity (Raina et al. 2008; Zhao & Majewski, 2008).
Arterial VM was assessed in a small complement of experiments by inserting a glass microelectrode backfilled with 1 m KCl (tip resistance = 120–150 MΩ) into the vessel wall (Knot & Nelson, 1995; Welsh et al. 2000). A control measure was first attained at 80 mmHg; the artery was then returned to 15 mmHg and ryanodine (50 m) added to the PSS. Following 5 min of equilibration, the vessel was returned to 80 mmHg and a second VM measurement was independently attained. The criteria for successful cell impalement included: (1) a sharp negative VM deflection upon entry; (2) a stable recording for at least 1 min following entry; and (3) a sharp return to baseline upon electrode removal.
Ca2+ wave measurements
The endothelium was removed from whole arteries, which were then equilibrated for 20 min in a Hepes buffer (pH 7.4; room temperature) containing (in mm): 134 NaCl, 6 KCl, 1 MgCl2, 2 CaCl2, 10 Hepes and 10 glucose (Jaggar & Nelson, 2000). Following equilibration, arteries were exposed (2 h) to a Hepes buffer containing 10 μm fluo-4 AM and 10 μm pluronic acid. Loaded arteries were washed (30 min) in PSS and then mounted for vessel myography as described above. To visualize Ca2+ waves, fluo-4-loaded arteries were excited at 488 nm using a krypton–argon laser (power, 5–8 mW). Emission spectra (510 nm) were viewed through a 63× water immersion objective (1.2 NA) coupled in series with a dual Nipkow Spinning Disk Confocal head (Solamere Technology Group, UT, USA) and a Mega-10 ICCD camera (Stanford Photonics, CA, USA). Image acquisition was limited to 30 s periods (10–20 frames s−1) to limit laser-induced tissue injury.
Movie file analysis
Movie files were analysed offline using software provided by Stanford Photonics (CA, USA). Briefly, starting with the first visibly loaded smooth muscle cell, a square box (∼1.5 μm × 1.5 μm) was placed on the next 10 successive cells that were in sharp focus. Changes in fluo-4 emission spectra were assessed at these fixed positions and data were normalized to baseline fluorescence (F0). To be classified as a Ca2+ wave, a particular event had to: (1) appear to spread from end to end; (2) demonstrate a peak fluorescence ∼15% above baseline; and (3) last longer than 200 ms. Ca2+ wave generation was quantified in terms of the percentage of cells firing Ca2+ waves and the frequency of these events per firing cell.
Measurement of MLC20 phosphorylation
A 2–3 mm segment of artery with the endothelium removed was cut in two, with each segment being mounted in an arteriograph. One half of each pair was then exposed to: (1) 20 or 80 mmHg intravascular pressure; (2) 80 mmHg intravascular pressure ± diltiazem (30 μm); or (3) 80 mmHg intravascular pressure + diltiazem ± ryanodine (10 or 50 μm) or thapsigargin (200 nm). Note that all agents were first applied to vessels resting at 15 mmHg (5 min) before being pressurized in a step-wise fashion to 20 or 80 mmHg. Arterial protein was subsequently extracted and MLC20 phosphorylation ascertained using a two-step Western blot approach as previously described (Takeya et al. 2008; Johnson et al. 2009). Briefly, cerebral artery extracts were electrophoresed (30 mA) on a Phos-tag SDS-PAGE gel for 1.5 h. Proteins were then transferred overnight to a PVDF membrane (4°C); the next day blotted membranes were initially washed (PBS, 5 min) and then exposed to a 0.5% glutaraldehyde PBS solution (45 min) to cross link and fix proteins. After a second set of washes in Tris-buffered saline (TBS), the membrane was blocked with 1.0% ECL blocking agent (GE Healthcare, Buckinghamshire, UK) in TBS containing 0.02% Tween-20 (TBST) for 1 h. The membrane was then incubated overnight in a TBST (0.1%) solution containing a rabbit anti-MLC20 antibody (1:1000 dilution). The next morning, the membrane was washed (TBST, 0.02%), and incubated in a TBST (0.1%) solution containing HRP–anti-rabbit antibody (1:10,000 dilution). The membrane was then washed for a final time in TBST (0.02%) and HRP detected with the Amersham ECL advance Western blotting detection kit (GE HealthCare). Emitted light was detected with a chemiluminescence image analyser and analysed with Multi Gauge v3.0 software (Fujifilm, ON, CA). MLC20 phosphorylation was expressed as a percentage of the total MLC20 protein pool.
Measurement of MYPT1 phosphorylation
Arterial protein extracts used in the assessment of MYPT1 phosphorylation were collected in a manner identical to the preceding MLC20 assay. In general accordance with Johnson et al. (2009), cerebral artery extracts were electrophoresed (30 mA) down a traditional 10% polyacrylamide gel for 2 h. This gel was then cut below the 70 kDa marker; the bottom and top half were then transferred to PVDF (75 min at 100 V, 4°C) and nitrocellulose (2 h at 100 V, 4°C), respectively. The PVDF membrane was subsequently washed in PBS, exposed to 0.5% gluteraldehdye in PBS (45 min), washed again (PBS) and then blocked (1 h) in a TBST (0.1%) solution containing 1.0% ECL blocking agent. Following a third set of washes (TBST, 0.02%), the PVDF membrane was placed overnight (4°C) in a TBST (0.1%) solution containing a rabbit anti-α smooth muscle actin antibody (1:1000). The next day, the membrane was washed again (TBST, 0.02%) and placed (1 h) in a TBST (0.1%) solution containing a HRP–anti-rabbit antibody (1:10,000). The membrane was then washed for a final time (TBST, 0.02%) and HRP detected by chemiluminescence. In contrast to PVDF, the nitrocellulose membrane was first stained with Ponceau S, washed in distilled water and then dried overnight on filter paper. The next day, the nitrocellulose membrane was blocked (1 h) in TBST (0.02%) containing 0.5% I-block and then transferred to a TBST (0.1%) solution containing a rabbit anti-phospho-MYPT1 antibody (1:1000, 1.5 h) directed against the T687 or the T855 site. The membrane was subsequently washed in TBST (0.02%) and placed in a TBST (0.1%) solution containing an anti-rabbit-IgG biotin conjugate (1:40,000, 1 h). Following this incubation period, the nitrocellulose membrane was washed in TBST (0.02%) and then placed in a TBST (0.1%) solution containing HRP–streptavidin (1:200,000, 30 min). Finally, the membrane was washed 5 more times in TBST (0.02%) and twice in TBS. HRP was subsequently detected by chemiluminescence as described in the preceding section. MYPT1 phosphorylation at the T697 or T855 site was standardized to α-actin and then expressed relative to 20 mmHg, 80 mmHg or 80 mmHg + diltiazem treatment.
Luminal Ca2+ imaging of HEK-293 cells expressing RyR2
To monitor luminal Ca2+ transients in HEK-293 cells, we used the Ca2+-sensitive fluorescence resonance energy transfer (FRET)-based chameleon protein D1ER (Palmer et al. 2004; Jones et al. 2008; Jiang et al. 2005). Briefly, HEK-293 cells which stably express RyR2 were transfected with D1ER cDNA 24 h prior to the induction of RyR2 with tetracycline (1 μg ml−1). After a 15 h stabilization period in cell culture, RyR2-expressing cells were perfused continuously at room temperature with buffer (in mm: 125 NaCl, 5 KCl, 1.2 KH2PO4, 6 glucose, 1.2 MgCl2, 25 Hepes, pH 7.4) containing CaCl2 (0 or 3 mm), ryanodine (50 μm), tetracaine (1 mm) and caffeine (5 mm). Using an inverted microscope equipped with a S-Fluor 20×/0.75 objective and a fluorescence camera, the D1ER protein was excited at 430 nm while emission spectra were captured at 470 and 535 nm using Simple PCI 6 software (Compix Inc., PA, USA) every 0.33 s. FRET was quantified by dividing the emission spectra at 535 nm by that collected at 470 nm. Control experiments were also performed on HEK-293 cells expressing D1ER but not RyR2.
Chemicals, drugs and enzymes
Bradykinin, caffeine, diltiazem, nifedipine, thapsigargin, cyclopiazonic acid, iberiotoxin and buffer reagents were purchased from Sigma-Aldrich (MO, USA). Fluo-4, fura-2 AM and pluronic acid were acquired from Molecular Probes (OR, USA) whereas ryanodine was obtained from Ascent Chemicals (NJ, USA). When required, stock agents were solubilized in DMSO and final solvent concentration did not exceed 0.05%. Primary, secondary and tertiary antibodies/substrates were obtained from the following sources: rabbit anti-MLC20, Santa Cruz Biotechnology (CA, USA); rabbit anti-α-actin, Abcam (MA, USA); rabbit anti-phospho-MYPT1, Millipore (MA, USA); anti-rabbit HRP, Thermo Scientific (ON, CA); anti-rabbit IgG biotin conjugate, Jackson Immuno Research (PA, USA); HRP–streptavidin, Thermo Scientific.
Data are expressed as means ±s.e.m., and n indicates the number of vessels or cells. No more than two experiments were performed on vessels from a given animal. Paired t tests were performed to compare the effects of a given condition/treatment on arterial diameter, Ca2+ wave frequency, VM or protein phosphorylation. P values ≤0.05 were considered statistically significant.
Pressure-induced responses in cerebral arteries
Cerebral arteries (with the endothelium removed) were mounted in an arteriograph, and exposed to intravascular pressures that varied from 20 to 100 mmHg. In the presence of extracellular Ca2+, arterial diameter was actively maintained across this pressure range and responses contrasted sharply with the passive distention observed in Ca2+-free PSS (Fig. 1A and B). The plotted difference between the active and passive response (Fig. 1C) further revealed the robust nature of the myogenic response. The principal Ca2+ event thought to drive myogenic reactivity is a global sustained rise in cytosolic [Ca2+] initiated by a depolarization that activates voltage-operated Ca2+ channels (Knot & Nelson, 1995, 1998; Knot et al. 1998; Welsh et al. 2000, 2002). While important, we hypothesized that elevated intravascular pressure might induce other events such as Ca2+ waves, described as discrete events that spread along the length of a cell and which are asynchronous among neighbouring myocytes (see Supplemental material for movie file). Using a systematic approach, Fig. 2A–C revealed that elevated pressure does indeed stimulate Ca2+ waves. Mean Ca2+ wave velocity at 80 mmHg was 61 ± 12 μm s−1 (n= 7), a value comparable to that of Jaggar (2001). Quantification revealed that the rise in Ca2+ wave generation, denoted by the percentage of cells firing these events and the number of waves per minute per firing cell, occurred primarily as cerebral arteries were modestly pressurized from 20 to 40 mmHg (Fig. 2D and E). Further pressurization to 80 mmHg elicited a modest but significant increase in the percentage of cells firing Ca2+ waves; event frequency also rose although this change was not statistically different.
Basis of pressure-induced Ca2+ waves
To ascertain the role of the SR in Ca2+ wave generation, this study used micromolar ryanodine to place RyR into a subconductance state and thereby deplete this Ca2+ store (Smith et al. 1988). To illustrate ryanodine's mechanistic effect, two sets of control experiments were conducted. The first deployed HEK-293 cells expressing RyR2, one of the dominant isoforms in vascular smooth muscle (Coussin et al. 2000), and a FRET-based probe to monitor [Ca2+] in the endoplasmic reticulum (ER). As noted in Fig. 3A and B, Ca2+ was periodically released from these cells under control conditions, and ryanodine and tetracaine both eliminated these events albeit through different mechanisms. Consistent with ryanodine functioning as a depleting agent, the loss of the preceding Ca2+ events coincided with an overall reduction in ER [Ca2+]. In contrast, the tetracaine-induced loss of Ca2+ release corresponded with a rise in ER [Ca2+], a finding indicative of true RyR2 blockade. The application of ryanodine (n= 59) or tetracaine (n= 51) to HEK-293 cells expressing D1ER but not RYR2 did not appreciably change the FRET ratio. The depleting action of ryanodine was secondarily confirmed in intact arteries by documenting the inability of caffeine to induce a smooth muscle Ca2+ transient following a 10 min exposure to this plant derivative (Fig. 3C and D). Having confirmed the depleting action of ryanodine, a complete range of Ca2+ wave measurements were subsequently performed on pressurized cerebral arteries to illustrate that the loss of the SR store dramatically reduced the proportion of smooth muscle cells firing Ca2+ waves along with the frequency of these events (Fig. 3E and F).
Previous studies have presented conflicting views as to the importance of voltage in Ca2+ wave generation (Jaggar, 2001; Kuo et al. 2003; Lee et al. 2005; Dai et al. 2006). To address this issue, we first examined the effects of Ca2+ channel blockade on these asynchronous events. Control experiments preceded this examination in which 30 μm diltiazem, a blocker of voltage-operated Ca2+ channels, was shown to eliminate KCl-induced constriction in cerebral arteries pressurized to 20 or 80 mmHg (Fig. 4A and B). Having confirmed blocker efficacy, diltiazem was subsequently added to pressurized arteries loaded with fluo-4 to show that Ca2+ channel inhibition did not affect the percentage of smooth muscle cells firing waves or the number of waves per minute per firing cell (Fig. 4C and D). To further illustrate the voltage insensitivity of Ca2+ wave generation, additional experiments monitored whether these asynchronous events were altered when arterial VM was manipulated through changes in extracellular [K+]. Findings in Fig. 5A, C and D illustrate that elevating [K+] to 15 mm, a challenge that hyperpolarizes and dilates cerebral arteries pressurized to 80 mmHg (Smith et al. 2008), had no measurable effect on the generation of Ca2+ waves. A 30 mm K+ challenge, a perturbation that depolarizes and constricts cerebral arteries pressurized to 20 or 40 mmHg was equally ineffective (Fig. 5B and E–H). Interestingly, ∼50% of the cerebral arteries pressurized to 40 mmHg and exposed to the 15 mm K+ challenge displayed, over time, vasomotion as defined by large-amplitude, spontaneous constrictions (Fig. 6A). When this oscillatory behaviour was present, the Ca2+ events within individual smooth muscle cells displayed considerable synchronicity (Fig. 6B). A quantitative assessment performed on discernable cells (Fig. 6C) revealed that the synchronized Ca2+ events were longer in duration and greater in magnitude than the asynchronous Ca2+ waves observed in arteries that do not display vasomotion.
Pressure-induced Ca2+ waves and arterial constriction
Having ascertained the voltage insensitivity of Ca2+ wave generation, we subsequently assessed whether or by what mechanism these events facilitate myogenic tone development. To accomplish this objective, we first monitored the diameter of pressurized arteries under control conditions and following a 5 min pre-incubation with diltiazem and/or ryanodine. Note that pre-incubation was performed with vessels resting at 15 mmHg. As the representative trace in Fig. 7A illustrates, diltiazem attenuated but did not completely abolish myogenic tone in arteries pressurized between 20 and 100 mmHg. Residual myogenic tone was diminished by a sizable extent by the further addition of 50 μm ryanodine. Interestingly, Fig. 7B revealed that the diltiazem-sensitive component of the myogenic response continuously rose as a function of intravascular pressure whereas the ryanodine-sensitive element peaked at 60 mmHg and was sustained thereafter. Reversing the order of agent application elicited a similar result, reinforcing the importance of Ca2+ wave generation in tone development particularly at low intravascular pressures (Fig. 7C and D). If nifedipine (100 nm) was used in place of diltiazem, myogenic tone was again attenuated and residual tone was markedly diminished by the application of ryanodine (Fig. 7E and F). Note that concentrations as low as 50 nm nifedipine will effectively block L-type Ca2+ currents in rat cerebral arterial smooth muscle cells (Adb El-Rahman et al. 2010). This concentration is in keeping with nifedipine's reported IC50 (10 nm) for the smooth muscle splice variant of the L-type Ca2+ channel. If nifedipine was elevated to 1 μm, a concentration ∼100 times above the reported IC50 for the splice variant (Liao et al. 2007), a similar pattern emerged (Fig. 7G and H). Myogenic tone was suppressed but not abolished and the nifedipine-insensitive component was attenuated by the further addition of ryanodine. At micromolar concentrations, the target specificity of nifedipine is a concern as past studies have noted that this agent can interfere with other Ca2+-permeable pores (Akaike et al. 1989a,b; Copello et al. 2007; Curtis & Scholfield, 2001; Nikitina et al. 2007).
The diltiazem/nifedipine-insensitive component highlighted in the preceding paragraph appears, on the surface, to be absent from the original studies of Knot (Knot & Nelson, 1998; Knot et al. 1998). However, a closer examination of this earlier work reveals that EGTA was not included in the zero Ca2+ media, which could lead to an improper assessment of maximal diameter and make it difficult to observe the diltiazem/nifedipine-dependent component. Findings in Fig. 8A and B support this perspective. Analogous to Knot (Knot & Nelson, 1998; Knot et al. 1998), PSS containing diltiazem or diltiazem/zero Ca2+ attenuates myogenic tone to a similar degree. Arterial diameter was not, however, maximal as the 2 mm EGTA/zero Ca2+ PSS elicited further dilatation at intravascular pressures ranging from 20 to 100 mmHg. The functional impact of this oversight becomes clear when diltiazem-sensitive tone is plotted proportionally to the total response range (maximal diameter – resting diameter). When maximal diameter is ascertained in diltiazem/zero Ca2+ PSS, diltiazem appears to block 73–95% of the purported tone (Fig. 8C). This percentage drops to 47–76% when maximal diameter is set in a zero Ca2+/2 mm EGTA PSS.
The ability of ryanodine to attenuate myogenic tone in diltiazem-treated vessels suggests that these Ca2+ waves augment MLC20 phosphorylation, not by altering arterial VM and consequently Ca2+ channel activity, but by providing Ca2+ directly for MLCK or perhaps MLCP regulation. Consistent with this perspective, direct biochemical measurements revealed that while diltiazem attenuates the pressure-induced increase in MLC20 phosphorylation, further reductions were achievable with the addition of ryanodine (Fig. 9A and B). Electrical measurements in Fig. 10 subsequently revealed that 50 μm ryanodine has little measurable effect on arterial VM. The ability of ryanodine to attenuate Ca2+ wave generation, myogenic responsiveness and MLC20 phosphorylation could be replicated with other SR-depleting agents. This is illustrated in Fig. 11 where thapsigargin (200 nm), an SR Ca2+-ATPase inhibitor, notably attenuated Ca2+ wave generation, pressure-induced constriction and MLC20 phosphorylation. Like ryanodine, the thapsigargin-sensitive component of the myogenic response peaked at lower intravascular pressures and remained constant above 60 mmHg. Cyclopiazonic acid's (10 μm) effect on myogenic tone parallels those of thapsigargin (n= 6, authors’ unpublished observations).
SR-dependent Ca2+ waves along with Ca2+ influx through voltage-operated Ca2+ channels augment MLC20 phosphorylation by either activating MLCK or inhibiting MLCP. While one cannot directly assess MLCK activity in intact rat cerebral arteries, MLCP activity can be inferred by measuring the phosphorylation state of MYPT1, a targeting/regulatory protein that directs the catalytic subunit of protein phosphatase 1 (PP1c) to myosin (Wooldridge et al. 2004; Wilson et al. 2005; Johnson et al. 2009). Findings in Fig. 12 illustrate that elevated intravascular pressure probably inhibits MLCP as MYPT1 phosphorylation increased at the T855 site. Consistent with Ca2+ influx through voltage-operated Ca2+ channels facilitating MLCP inhibition, diltiazem attenuated but did not completely abolish T855 phosphorylation. In the presence of diltiazem, the addition of 50 μm ryanodine or 200 nm thapsigargin further lowered T855 phosphorylation indicating a role for voltage-insensitive Ca2+ waves in the modulation of phosphatase activity. The phosphorylation state of T697 was unaffected by elevated intravascular pressure or the subsequent addition of diltiazem, ryanodine or thapsigargin.
The preceding ryanodine findings appear, on the surface, to contradict previous studies showing that this plant alkaloid elicits arterial constriction (Knot et al. 1998; Yang et al. 2009). This difference in vasomotor responsiveness did not result from the lower ryanodine concentration used in past investigations, as Fig. 13A and B shows that at 10 μm this agent continues to attenuate myogenic tone development. A more likely explanation centres on the vessel's activation state when ryanodine is first applied. For example, Fig. 14A and B highlights that 10 μm ryanodine can indeed elicit a sustained constriction if arteries are pressurized to 80 mmHg. At higher intravascular pressures, ryanodine will probably induce constriction as the contractile apparatus is more sensitized to Ca2+ (Fig. 12) and smooth muscle cells have difficulty extruding SR Ca2+ as their depolarized state impairs forward-mode Na+/Ca2+ exchange activity (Kargacin & Fay, 1991; Raina et al. 2008; Zhao & Majewski, 2008). In support of the Na+/Ca2+ exchange argument, this study noted that the introduction of a brief hyperpolarization period (5 min) to promote forward-mode Na+/Ca2+ exchange activity, attenuated ryanodine-induced constriction at 80 mmHg (Fig. 14C and D). Hyperpolarization was promoted in this experimental protocol by lowering intravascular pressure and elevating extracellular [K+] (15 mm) to augment the activity of inward rectifying K+ channels. Interestingly, if Na+/Ca2+ exchange activity was blocked during the hyperpolarization period with an equilmolar substitution of LiCl (120 or 60 mm) for NaCl, ryanodine-induced constriction at 80 mmHg did not reverse (Fig. 14E and F). Similar results were obtained if NMDG-Cl (60 mm) was used as the ionic replacement for NaCl (Fig. 14G and H). This latter experiment is important in that it confirms that the lack of tone reversal by LiCl is unrelated to its ability, over the long term, to interfere with phosphatidylinositol synthesis (Galeotti et al. 2004).
This study examined whether elevated intravascular pressure stimulates Ca2+ waves and how their generation might contribute to myogenic tone development in the cerebral circulation. We report that elevated intravascular pressure augments the generation of asynchronous Ca2+ waves in cerebral arterial smooth muscle cells. The pressure-induced augmentation of these SR-driven events was particularly pronounced below 60 mmHg and was insensitive to voltage as Ca2+ channel blockade and perturbations in extracellular [K+] had no measurable effect on the percentage of cells firing Ca2+ waves or event frequency. The elimination of SR-dependent Ca2+ waves attenuated myogenic tone, an effect that was proportionally greater at lower intravascular pressures. Subsequent experiments revealed that these asynchronous Ca2+ events facilitate pressure-induced constriction not by initiating a dramatic change in arterial VM but by directly providing a proportion of the Ca2+ needed to drive MLC20 phosphorylation. The ability of Ca2+ waves to augment MLC20 phosphorylation was attributed to this divalent's ability to activate MLCK and to inhibit MLCP as inferred through changes in MYPT1 phosphorylation. In closing, this investigation argues that while SR-driven Ca2+ waves are indeed asynchronous and transient in nature, they are fully capable of modulating MLC20 phosphorylation and directing pressure-induced constriction in the cerebral vasculature.
Basis of pressure-induced Ca2+ waves
Bayliss is acknowledged as first suggesting that arterial tone is regulated by changes in intravascular pressure (Bayliss, 1902). Since his initial observations, the myogenic response has been observed in a variety of vascular beds including the cerebral circulation where it is essential to maintain constant perfusion over a range of blood pressures (Welsh et al. 2000, 2002; Hill et al. 2001; Loutzenhiser et al. 2002; Slish et al. 2002). Like any vasoactive stimulus, intravascular pressure mediates arterial tone by altering MLC20 phosphorylation, a process under the dynamic control of MLCK and MLCP (Knot & Nelson, 1998; Davis et al. 2001; Johnson et al. 2009). Mechanistic studies have strongly emphasized the idea that pressure-induced constriction was intimately linked to a global rise in cytosolic [Ca2+]. They particularly argued that pressure-induced increases in cytosolic [Ca2+] were driven by the depolarization of vascular smooth muscle and a sustained influx of Ca2+ through voltage-operated Ca2+ channels (Knot & Nelson, 1995, 1998; Knot et al. 1998; Welsh et al. 2000, 2002). While this perspective is firmly based on a breadth of observations, it is conceivable that there are additional means for a mechano-stimulus to elevate cytosolic [Ca2+]. In theory, a pressure stimulus could induce asynchronous Ca2+ waves, SR-driven events that most often start and terminate at the ends of vascular smooth muscle cells. Studies of pressure-induced Ca2+ waves have to date been inconclusive. For example, Miriel et al. (1999) noted that fewer than 10% of smooth muscle cells consistently fired Ca2+ waves in pressurized cerebral arteries, a finding that contrasts with Jaggar (2001) who reported that this mechano-stimulus increased the frequency of these events. Mesenteric observations have also added to this lack of consensus by noting that pressurization induces ‘Ca2+ ripples’, a subtle oscillatory event maintained on top of a sustained rise in cytosolic [Ca2+] (Zacharia et al. 2007).
It was within this context that we addressed whether elevated intravascular pressure sustainably induces Ca2+ waves in cerebral arteries. Initial experiments reconfirmed the robust nature of the myogenic response, with its magnitude progressively increasing as pressure was stepped from 20 to 100 mmHg (Fig. 1). Consistent with Jaggar (2001), we observed that elevated pressure augmented Ca2+ wave generation in cerebral arterial smooth muscle cells. This augmentation, quantified as the percentage of cells firing Ca2+ waves and event frequency per firing cell, was particularly pronounced as arteries were initially pressured from 20 to 40 mmHg. Pressure-induced Ca2+ waves were sustainably generated and observable by confocal microscopy as long as vessels were not overloaded with fluo-4 and irradiation time was limited to less than 2 min. When irradiation exceeded this defined period, Ca2+ wave generation dramatically decreased, global fluo-4 fluorescence rose and arteries irreversibly constricted. These changes are indicative of laser-induced tissue damage and perhaps it is this type of injury that prevented Miriel et al. (1999) from observing pressure-induced Ca2+ waves in the cerebral circulation.
Past studies have consistently shown that constrictor agonists augment Ca2+ wave generation through the release of SR Ca2+ (Jaggar & Nelson, 2000; Kuo et al. 2003; Lamont & Wier, 2004; Lee et al. 2005). This perspective grew from an experimental approach which revealed that when Ca2+ release was impaired through the inhibition of IP3 receptors or the reuptake of SR Ca2+, there was a dramatic decline in the generation of these asynchronous events (Kuo et al. 2003; Lamont & Wier, 2004; Lee et al. 2005). The SR dependency of pressure-induced Ca2+ waves was confirmed in the current investigation by superfusing tissues with ryanodine, a plant alkaloid that binds RyR, placing it into a subconductance state that slowly depletes SR Ca2+ (Fig. 3) (Smith et al. 1988). Having clearly ascertained that mechanical stimuli induce SR-driven Ca2+ waves, subsequent experiments focused on whether these events were dependent upon Ca2+ influx through voltage-operated Ca2+ channels. Our interest in this question stems from the work of Jaggar (2001) who argued that without membrane depolarization and the subsequent activation of L-type Ca2+ channels to refill the SR store, it was not possible to maintain these asynchronous Ca2+ events. Contrary to this view, two general sets of observations argue against a close association. First, diltiazem, a blocker of voltage-operated Ca2+ channels, had no appreciable effect on Ca2+ wave generation (Fig. 4). Second, raising extracellular [K+] in a manner that hyperpolarizes or depolarizes pressurized arteries over a range of approximately 20 mV (Knot & Nelson, 1995, 1998; Welsh et al. 2000), did not influence the percentage of cells firing Ca2+ waves or the frequency of these events (Fig. 5). The voltage insensitivity of pressure-induced Ca2+ waves is perhaps unsurprising in that when membrane potential does govern the Ca2+ release process (e.g. myocardium), the SR Ca2+ transients among the neighbouring cells are typically synchronized (Bers, 2008). Interestingly, synchronized Ca2+ events were occasionally observed in pressurized cerebral arteries exposed to 15 mm extracellular [K+] (Fig. 6). While the dramatic changes in arterial diameter often impaired our ability to consistently apply quantitative analysis, the data collected from ∼20 discernible cells revealed that synchronized Ca2+ events displayed temporal and spatial characteristics different from their asynchronous cousins. In particular, this study observed that the overall duration and magnitude of the synchronized Ca2+ events was ∼2- to 3-fold greater than asynchronous Ca2+ waves. Intriguingly, this study also documented evidence of a two-step release process, similar to that of rat Purkinje cells (Stuyvers et al. 2005). Perhaps a concerted biophysical focus on such synchronized events might, in the future, yield new insights into the basis of excitation–contraction coupling in vascular smooth muscle.
Function of pressure-induced Ca2+ waves
In the vascular literature, Ca2+ influx through voltage-operated Ca2+ channels is thought to be responsible for MLCK and/or MLCP modulation, and the induction of myogenic tone (Knot & Nelson, 1995, 1998; Knot et al. 1998; Welsh et al. 2000, 2002). Ca2+ waves have received less attention, and if invoked, they are thought to have a restricted effect on tone development (Jaggar, 2001). To address this, a set of experiments were performed in which the diameter of pressurized cerebral arteries was monitored under conditions in which diltiazem and/or ryanodine were used to block voltage-operated Ca2+ channels and deplete the SR Ca2+ store, respectively. Consistent with past investigations, this study confirmed that Ca2+ influx via voltage-operated Ca2+ channel activation does play a pivotal role in myogenic tone development (Fig. 7) (Knot & Nelson, 1995, 1998; Knot et al. 1998). Interestingly, diltiazem did not completely eliminate myogenic tone, an observation suggestive of an additional source of Ca2+ contributing to tone development. Consistent with SR Ca2+ waves operating as this additional source, ryanodine application reduced the diltiazem-insensitive component of the myogenic response. Interestingly, diltiazem-sensitive tone continuously rose as a function of intravascular pressure whereas the ryanodine-sensitive element peaked at 60 mmHg and was constant thereafter. Reversing the order of agent application produced a quantitatively similar effect as did experiments in which nifedipine was used in place of diltizem to block voltage-operated Ca2+ channels. Caution is required when working with dihydropyridines as there are persistent observations that low micromolar concentrations can have secondary effects on other Ca2+ handling mechanisms (Akaike et al. 1989a; Copello et al. 2007; Curtis & Scholfield, 2001; Kumar et al. 2002; Nikitina et al. 2007). For example, Curtis & Scholfield (2001) reported that at 1 μm, nifedipine interferes with the refilling of the SR through a non-L-type Ca2+ channel. Others have reported that at concentrations commonly used in the vascular field, dihydropyridines can block T-type Ca2+ channels (Akaike et al. 1989a,b; Nikitina et al. 2007). Such findings are not, however, universal (Kuo et al. 2010).
The diltiazem/nifedipine-insensitive component described above appears, on the surface, to vary from the original work of Knot (Knot & Nelson, 1998; Knot et al. 1998) who noted L-type Ca2+ channel blockers elicit a near-complete block of the myogenic response. However, a more detailed analysis of this earlier work reveals that EGTA was not included in the zero Ca2+ media, an omission that would impact on the assessment of maximal diameter and the relative importance of L-type Ca2+ channels. The experiments in Fig. 8 supported this particular view. Like Knot (Knot & Nelson, 1998; Knot et al. 1998), PSS containing diltiazem or diltiazem/zero Ca2+ attenuated myogenic tone to a similar degree. Arterial diameter was not, however, maximal as a 2 mm EGTA/zero Ca2+ PSS further dilated cerebral arteries at all intravascular pressures. The functional impact of oversight is evident in Fig. 8C when one plots diltiazem-sensitive tone proportionally to the total response range (maximal diameter – resting diameter). Note the variant picture that emerges depending on whether maximal diameter is ascertained in a diltiazem/zero Ca2+ or 2 mm EGTA/zero Ca2+ PSS. In the former, diltiazem blocks 73–95% of the available tone whereas in the latter, this Ca2+ channel blocker only attenuates 47–76%.
Overall, the findings in Figs 2–8 indicate that Ca2+ waves probably provide a proportion of the Ca2+ required to activate MLCK and/or inhibit MLCP. In support of this interpretation, our Western blotting data showed that while diltiazem attenuated pressure-induced MLC20 phosphorylation, one could further diminish phospho-protein content with the further application of ryanodine (Fig. 9). These particular results raise interesting questions with respect to the presumed role of the SR in regulating contractile function. One theory is that the principal function of SR Ca2+ release is to control the electrical state of vascular smooth muscle through the regulation of Ca2+-sensitive ion channels. This perspective initially developed from electrophysiological observations showing that discrete SR events called ‘Ca2+ sparks’ activate BK channels and elicit spontaneous transient outward currents (Jaggar et al. 1998b; Perez et al. 1999, 2001). It has been further fostered by findings attempting to link Ca2+ wave generation to the activation of transient receptor potential channels (Gonzales et al. 2010). While an interesting perspective, this study did not observe a substantive relationship between SR Ca2+ release and ion channel activity as ryanodine application failed to alter arterial VM under conditions in which Ca2+ spark and Ca2+ wave activity should be optimal (Fig. 10). While no measurable changes were observed, caution is warranted in extending the interpretation. In theory, Ca2+ sparks may indeed be activating BK channels but their contribution to arterial VM might be more modest than previously noted (Knot et al. 1998) and below our resolution limit (∼3 mV). This perspective to some degree is consistent with computational results which show that near-maximal values of STOC frequency and amplitude can at best elicit a 5 mV change in arterial VM (Diep et al. 2005). Alternatively, it could be argued that as a SR-depleting agent, ryanodine would not only eliminate the hyperpolarizing influence of Ca2+ spark generation, but the depolarizing influence stemming from Ca2+ wave production and the activation of TRPM4 channels (Gonzales et al. 2010).
Ryanodine has several perceived advantages over other agents used to deplete the SR Ca2+ store. First, ryanodine retains a high target selectivity and its mechanism of action is well documented in the cardiovascular literature (Dibb et al. 2007; Gyorke & Terentyev, 2008). It is also less likely to mobilize endothelial Ca2+ stores as this cell type does not normally express RyR (Ledoux et al. 2008). Despite these advantages, it is important to employ other SR-depleting agents such as thapsigargin. Figure 11 shows that this Ca2+-ATPase inhibitor compromises Ca2+ wave generation, myogenic tone development and MLC20 phosphorylation in a manner similar to ryanodine. Thus, our observations consistently show that Ca2+ liberated from the SR store plays a direct role in mediating pressure-induced constriction. In theory, Ca2+ waves could facilitate MLC20 phosphorylation by directly regulating MLCK via divalent binding to low-affinity sites on calmodulin (Walsh et al. 1995). Alternatively, Ca2+ waves could facilitate MLCP inhibition through an undetermined effect on Rho-kinase (Sward et al. 2000) or a PKC-mediated event involving CPI-17, a phospho-regulatory protein (Dimopoulos et al. 2007; Kitazawa et al. 2009). While MLCK cannot be dynamically assayed in rat cerebral arteries, MLCP activity can be inferred by measuring MYPT1 phosphorylation. MYPT1 is a targeting/regulatory protein that directs the catalytic subunit of PP1c to myosin (Wooldridge et al. 2004; Wilson et al. 2005; Johnson et al. 2009). When phosphorylated at T697 or T855, PP1c activity will decrease, an event that will precipitate MLC20 phosphorylation (Wooldridge et al. 2004; Wilson et al. 2005; Johnson et al. 2009). Consistent with past investigations (Johnson et al. 2009), this study documented the ability of elevated intravascular pressure to enhance MYPT1 T855 phosphorylation (Fig. 12). Indicative of SR Ca2+ waves driving MLC20 phosphorylation partially through MLCP inhibition, ryanodine and thapsigargin application both reduced T855 phosphorylation in diltiazem-treated arteries.
In presenting the preceding observations, it is important to acknowledge past investigations which have shown that instead of attenuating arterial tone, SR-depleting agents like ryanodine promote vessel constriction (Knot et al. 1998; Yang et al. 2009). Control experiments confirmed that this dichotomy was unrelated to subtle differences in ryanodine concentration (Fig. 13A and B) but was probably the predictable consequence of applying this plant alkaloid to vessels residing at different activation states. To elaborate, past studies have typically applied ryanodine to arteries exposed to intravascular pressures more than 60 mmHg (Knot et al. 1998; Yang et al. 2009). At higher pressure, ryanodine will probably induce arterial constriction as the contractile apparatus is more sensitized to Ca2+ (Fig. 12) and smooth muscle cells have greater difficulty extruding SR Ca2+ as their depolarized state impairs forward operation of the Na+/Ca2+ exchanger (Kargacin & Fay, 1991; Raina et al. 2008; Zhao & Majewski, 2008; Johnson et al. 2009). In contrast to previous work, this study introduced ryanodine to cerebral arteries resting at low intravascular pressure (15 mmHg). In this less stimulated state, Ca2+ sensitization is reduced and the hyperpolarized state of vascular smooth muscle will facilitate SR Ca2+ removal by promoting forward-mode Na+/Ca2+ exchanger activity. This study presents three key findings to support this general perspective (Fig. 14). First, we report that ryanodine induces arterial constriction if this agent is introduced to vessels pressurized to 80 mmHg. Second, we show that ryanodine-induced constriction can be partly reversed if tissues are briefly hyperpolarized to promote forward-mode Na+/Ca2+ exchanger activity. Lastly, if the Na+/Ca2+ exchanger is blocked during the hyperpolarization period, by an equilmolar substitution of LiCl/NMDG-Cl for NaCl, the preceding reversal of ryanodine-induced constriction is eliminated. While caution is warranted with ion substitution experiments, as a reduction in Na+ could affect other Na+-dependent transporters, these experiments help to rationalize ryanodine's dichotomous ability to influence arterial tone. These findings also raise significant questions as to the best methods of applying SR-depleting agents to probe the functional role of this internal store in resistance arteries. As most investigations aspire to compromise SR Ca2+ dynamics without dramatically influencing cytosolic [Ca2+], best practice would appear to dictate that SR-depleting agents should be applied to unstimulated arteries, residing in a hyperpolarized state.
In the past, studies of the myogenic response have argued that pressure-induced constriction fundamentally arises from the activation of a mechano-sensitive inward current which depolarizes vascular smooth muscle and induces a sustained influx of extracellular Ca2+ via the voltage-operated Ca2+ channels (Knot & Nelson, 1995, 1998; Welsh et al. 2000, 2002). While important, the present study introduces the idea that the internal SR store also provides a proportion of Ca2+, in the form of an asynchronous and voltage-insensitive wave, needed to sustain this physiological response. It also highlights that such events, along with Ca2+ influx through voltage-operated Ca2+ channels, retain an ability not only to activate MLCK but to inhibit MLCP (Fig. 15). Overall, our findings raise an important philosophical question centred on why two different Ca2+ responses are needed to initiate and maintain myogenic tone. In theory, the temporal characteristics of the two Ca2+ responses could enable smooth muscle to variably activate different Ca2+-dependent processes involved in MLC20 phosphorylation and cellular contraction (Walsh et al. 1995; Sward et al. 2000; Dimopoulos et al. 2007). Alternatively, it could be the voltage dependency/independency of the two events and not their temporal characteristics that are functionally important. For example, by decoupling Ca2+ wave generation from voltage, tissues are ensured that a Ca2+ source is always available to maintain some arterial tone even at hyperpolarized potentials where the overall activity of voltage-operated Ca2+ channels, albeit L- or the newly defined T-type, is more limited (Knot & Nelson, 1995; Kuo et al. 2010). This perspective is congruent with the fact that Ca2+ wave generation and its contribution to tone development was proportionally greater at lower intravascular pressures.
Further work is required to resolve which ion channels enable mechanical stimuli to generate SR-dependent Ca2+ waves. Given that phospholipase C inhibition limits myogenic tone development, it is logical to assume a role for IP3 receptors in asynchronous wave generation (Osol et al. 1993). It would be imprudent, however, to completely exclude RyR. As to a triggering event, some form of a Ca2+-induced Ca2+ release may underlie the overall process. Smooth muscle is notable for the expression of several Ca2+-permeable channels and if properly positioned, localized Ca2+ influx could induce the described SR-driven event (Knot & Nelson 1998; Nikitina et al. 2007; Earley & Brayden, 2010). Channels that operate independent of voltage would be of particular interest although one cannot exclude, a priori, T-type Ca2+ channels. In theory, if T-type Ca2+ channels were clustered, like the L-type, they might be able to generate a sparklet-like event without displaying normal voltage-dependent properties (Navedo et al. 2006).
R.E.M.: Conception, design, analysis and interpretation of all functional and biochemistry based experiments. Contributed to the intellectual content and final draft of the published manuscript. S.E.B.: Conception, design, analysis and interpretation of the Calcium wave experiments. Contributed to the editing of draft manuscripts. C.H.T.T.: Conception, design, analysis and interpretation of the membrane potential experiments. R.A.E.R., Y.A., A.E.Y. and W.C.C.: Aided in the implementation and design of the biochemistry and membrane potential experiments. Contributed to the editing of draft manuscripts. P.P.J. & W.S.W.C.: Design, analysis and interpretation of all HEK293 expression experiments. Contributed to the editing of draft manuscripts. D.G.W.: Conception and design of experiments, analysis and interpretation of data, drafting the article and revising it critically for important intellectual content, and final approval of the version to be published. All authors have approved the final draft of the manuscript.
This work was principally supported by an operating grant from the Canadian Institute of Health Research (CIHR) and the Natural Science and Engineering Research Council of Canada to DGW. Supplemental funding for Fig. 12 was also provided from CIHR operating grant to W.C.C. D.G.W. is a senior scholar with the Alberta Heritage Foundation for Medical Research (AHFMR) and holds a Canada Research Chair; W.S.W.C. is a scientist with AHFMR; W.C.C. is the Andrew Family Professor in Cardiovascular Research. R.E.M., A.E.-Y. and P.P.J. receive stipend support from the Saudi Arabian Cultural Ministry, AHFMR & CIHR, and AHFMR & Heart/Stroke Foundation of Canada, respectively.